Trexquant Investment LP Amryt Pharma PLC Transaction History

Trexquant Investment LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$7.0 - $14.77 $80,325 - $169,485	-11,475 Reduced 52.35%	10,446 $152,000
Q4 2022 Feb 13, 2023	SELL	$6.68 - $7.58 $76,900 - $87,260	-11,512 Reduced 34.43%	21,921 $160,000
Q3 2022 Nov 14, 2022	BUY	$6.8 - $8.01 $11,458 - $13,496	1,685 Added 5.31%	33,433 $231,000
Q2 2022 Aug 11, 2022	SELL	$6.85 - $8.87 $35,222 - $45,609	-5,142 Reduced 13.94%	31,748 $222,000
Q1 2022 May 13, 2022	BUY	$6.3 - $10.86 $163,711 - $282,207	25,986 Added 238.32%	36,890 $305,000
Q4 2021 Feb 14, 2022	SELL	$9.44 - $12.24 $78,125 - $101,298	-8,276 Reduced 43.15%	10,904 $118,000
Q3 2021 Nov 12, 2021	BUY	$9.63 - $12.47 $184,703 - $239,174	19,180 New	19,180 $231,000

142K

Ticker AMYT
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 64,177,000
Description
Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.